CPhT CONNECT™ Magazine - Volume 5 Issue 2

ce

The NIOSH Hazardous Drug List

fingolimod

"Immunomodulatory agents"

No

No

fluconazole

Azole antifungal

No No No No No No

Yes

fluoxymesterone

Androgens

No No No

flutamide

Antineoplastic agents

fosphenytoin

Hydantoin

fulvestrant

Antineoplastic agents Antigonadotropins

Yes Yes Yes Yes Yes Yes Yes

ganirelix

gonadotropin, chorionic

Gonadotropins

Yes

goserelin histrelin

Gonadotropins; antineoplastic agents

No No No No

"Gonadotropins. Antineoplastic agents" Complement inhibitors

icatibant

isotretinoin

Skin and mucous membrane agents, miscellaneous

ivabradine

"Cardiac drugs, miscellaneous"

No

Yes

leflunomide

"Disease-modifying antirheumatic agents. Immunomodulatory agents"

No

No

lenvatinib letrozole leuprolide

Antineoplastic agents

No No No

Yes Yes Yes

Antiestrogens: antineoplastic agents

"Gonadotropins. Antineoplastic agents" "Antilipemic agents, miscellaneous" "Vasodilating agents. Vasodilating agents, miscellaneous" Progestins; contraceptives

lomitapide

No

Yes

macitentan

No

Yes

medroxyprogesterone

No No No No No No No No No No No No No No

Yes

megestrol

Progestins; antineoplastic agents

No No

methimazole

Antithyroid agents

methylergonovine methyltestosterone

Oxytocics Androgens Oxytocics

Yes

Yes***

mifepristone miltefosine mipomersen

Yes Yes

Miscellaneous antiprotozoal "Antilipemic agents, miscellaneous; antisense oligonucleotides"

No

misoprostol

Prostaglandins

Yes

mycophenolic acid

"Immunosuppressive agents"

No

nafarelin

Gonadotropins

Yes

nevirapine

HIV nonnucleoside reverse transcrip- tase inhibitors

No

nilotinib olaparib

Antineoplastic agents Antineoplastic agents

Yes

No

CPhT CONNECT

www.cphtconnect.com 42

Made with FlippingBook - PDF hosting